Skip to main content

Together we are beating cancer

Donate now

Immunotherapy

Showing 12 out of 215 results
This entry is part 7 of 23 in the series Science Surgery

We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research. We spoke to Professor Margaret Frame, from the Cancer Research UK Edinburgh Centre, about her OBE for her contribution to cancer research.

by Gabriella Beer | Analysis | 24 January 2018

24 January 2018

Reovirus

Infecting tumours with viruses may boost the success of immunotherapy for brain and breast cancers, according to two new studies. Infecting tumours with viruses may boost the success of immunotherapy for brain and breast cancers, according to two new studies.

by Cancer Research UK | News | 3 January 2018

3 January 2018

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease. A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

by Justine Alford | Analysis | 26 September 2017

26 September 2017

Two clinical trials have found that existing treatments for advanced melanoma could stop the cancer returning in some people with earlier stage disease. Two clinical trials have found that existing treatments for advanced melanoma could stop the cancer returning in some people with earlier stage disease.

by Cancer Research UK | News | 12 September 2017

12 September 2017

Viruses may improve the success rate of immunotherapy treatments, according to two new studies. Viruses may improve the success rate of immunotherapy treatments, according to two new studies.

by Cancer Research UK | News | 8 September 2017

8 September 2017